Objective-Kindlin-3 is a critical supporter of integrin function in platelets. Lack of expression of kindlin-3 protein in patients impairs integrin αIIbβ3-mediated platelet aggregation. Although kindlin-3 has been categorized as an integrinbinding partner, the functional significance of the direct interaction of kindlin-3 with integrin αIIbβ3 in platelets has not been established. Here, we evaluated the significance of the binding of kindlin-3 to integrin αIIbβ3 in platelets in supporting integrin αIIbβ3-mediated platelet functions. Approach and Results-We generated a strain of kindlin-3 knockin (K3KI) mice that express a kindlin-3 mutant that carries an integrin-interaction defective substitution. K3KI mice could survive normally and express integrin αIIbβ3 on platelets similar to their wild-type counterparts. Functional analysis revealed that K3KI mice exhibited defective platelet function, including impaired integrin αIIbβ3 activation, suppressed platelet spreading and platelet aggregation, prolonged tail bleeding time, and absence of platelet-mediated clot retraction. In addition, whole blood drawn from K3KI mice showed resistance to in vitro thrombus formation and, as a consequence, K3KI mice were protected from in vivo arterial thrombosis. Conclusions-These observations demonstrate that the direct binding of kindlin-3 to integrin αIIbβ3 is involved in supporting integrin αIIbβ3 activation and integrin αIIbβ3-dependent responses of platelets and consequently contributes significantly to arterial thrombus formation. 
I
ntegrin αIIbβ3 on platelets plays a major role in vascular homeostasis by mediating platelet aggregation. 1, 2 As expressed on circulating platelets, the integrin αIIbβ3 receptors exist in a quiescent state where they exhibit low affinity for their cognate ligands. However, on encounter with stimulatory agonists, the integrin receptors undergo a transformation to a state in which they can orchestrate productive functional responses, including formation of platelet aggregates leading to artery thrombus formation. Such integrin activation depends on 2 intracellular proteins: talin and kindlin. [3] [4] [5] [6] Talin is involved in integrin activation by virtue of its binding to the cytoplasmic tail (CT) of the integrin β subunit. 7 In the absence of agonists, talin exists in the cytosol in an autoinhibited state in which its rod domain interacts with and shields the integrin-binding site within the F3 subdomain of the talin head domain. 8, 9 This autoinhibition is relieved by multiple mechanisms that encourage talin to interact with membrane and the integrin β CT, thereby disrupting the integrin α/β CT complex. 10 The kindlins, consisting of 3 members in mammals (kindlin-1, kindlin-2, and kindlin-3), are also capable of binding to the integrin β CT through their own F3 subdomains, but they bind primarily to a different site than talin. [11] [12] [13] Although the essential role of kindlins in supporting integrin activation has been established by in vivo deficits in integrin function associated with their deficiencies, 14, 15 their mechanism of action is unclear. Kindlins do not dissociate the integrin α/β CT complex and do not enhance the capacity of talin to dissociate the CT complex, 16 events that are necessary for integrin activation.
Kindlin-3 is preferentially expressed in and particularly important for the function of integrins on hematopoietic cells. 13, 17 Deficiency of kindlin-3 expression in humans causes type III leukocyte adhesion deficiency (LAD-III), which is associated with an inability to activate integrins on platelets and leukocytes and manifests as susceptibility to bleeding and infections. [18] [19] [20] [21] To date, multiple distinct mutations in kindlin-3 gene have been identified in patients with LAD-III, which all lead to the absence of kindlin-3 protein expression in blood cells, but the severity of symptoms in the patients has been variable. 22, 23 For example, only 1 patient with LAD-III was reported to have abnormally shaped red blood cells. 24 Genetically modified mice with deficiency of kindlin-3 have been described and do exhibit the defects in platelet and leukocyte functions observed in patients with LAD-III 13,25 that were attributable to an inability to activate multiple integrin subclasses. However, these mice only survived 1 week, 13 and, although their erythrocytes were misshaped, their shape was unlike that seen in the 1 human patient. 24, 26 Also, the kindlin-3 knockout mice displayed altered expression of multiple genes in hematopoietic cells, 26 including integrins, suggesting that the integrin dysfunction in kindlin-3-deficient mice might arise from effects unrelated from the direct interaction of kindlin-3 with integrin.
For kindlin-1 and kindlin-2, reconstitution experiments have clearly shown that the integrin-binding site in their F3 subdomain is important for integrin activation in model cells. 12, 27 Even though kindlin-3 is similar to the other 2 family members, to assume a similar mechanism of action might be premature. A recent finding showed that ADAP, an adaptor protein restricted to hematopoietic cells, recruits talin and kindlin-3 to integrin αIIbβ3 in platelets and raises the possibility that kindlin-3 activates integrin independent of direct binding. 28 Adding further to this uncertainty are the recent observations that kindlin-3 had no effect on integrin activation in nanodiscs in which talin head induced a measurable effect 29 and the in vivo observation that kindlin-2 could exert integrin-independent functions. 30 These findings bring into question the premise that direct interaction of kindlin-3 and integrin is essential for its regulation of hematopoietic cell responses that are blunted in kindlin-3 deficient mice and human patients.
In this study, we have generated kindlin-3 gene knockin (K3KI) mice that carry a mutation that disrupts the interaction of kindlin-3 with integrin αIIbβ3. Using this animal model, we demonstrate that the direct contact between kindlin-3 and integrin αIIbβ3 is indeed required to support integrin function in platelets in arterial thrombosis.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Identification of an Integrin InteractionDefective Substitution in Kindlin-3 protein
The inability of kindlin-3 to influence αIIbβ3 activation in nanodiscs 29 ; the ability of kindlin-3 to be recruited to integrin together with talin by adaptor proteins 28 ; and the effects of kindlin-3 deficiency on integrin and many other protein expression levels in mice 26 are among the data that bring into question the role of the direct interaction between kindlin-3 and integrins in controlling the responses of hematopoietic cells. These uncertainties prompted us to test initially whether kindlin-3 does indeed share the same integrin-binding properties as kindlin-1 and kindlin-2. A double-substitution (QW/AA) in the F3 subdomains of kindlin-1 and kindlin-2 has been shown to disrupt the interaction of integrin β CTs with kindlin-1 and kindlin-2, 11, 12, 27 and the corresponding substitutions were introduced into kindlin-3 ( Figure 1A ). Using a previously established flow cytometrybased protein-peptide interaction assay, 31 we attached EGFPkindlin-3 and EGFP-kindlin-3 mutant from transfected cell lysates to microbeads and measured their interaction with the biotinylated integrin β 3 CT peptides by flow cytometry. To
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CT cytoplasmic tail K3KI kindlin-3 knockin LAD-III type III leukocyte adhesion deficiency Figure 1 . The QW/AA substitution in kindlin-3 protein blocks integrin β 3 cytoplasmic tail (CT) recognition. A, The QW residues in the kindlin-3-F3 subdomain were substituted with 2 alanine residues. B, Microbeads coated with protein G were used for testing the interaction of kindlin-3 with integrin β 3 CT peptide. EGFP-fused kindlin-3 (EGFP-kindlin-3), EGFP-fused kindlin-3 mutant (EGFP-kindlin-3-AA), or EGFP alone were transiently expressed in CHO cells and then coupled onto microbeads via an anti-EGFP antibody. EGFP or EGFP-kindlin-3 loaded microbeads were extensively washed and incubated with the biotinylated integrin β 3 CT peptides followed by streptavidin conjugated with Alexa Fluor 633. The loading of EGFP and EGFP fusions on the microbeads and the binding of integrin β 3 CT peptides to EGFP-fused kindlin-3 on the microbeads were analyzed on a BD LSRII Flow Cytometer. C, EGFP-fused kindlin-3 (EGFP-kindlin-3) and EGFPfused kindlin-3 mutant (EGFP-kindlin-3-AA) carrying the QW/AA substitution were expressed in CHO cells and subjected to native PAGE under nonreducing and nondenaturing conditions. The migration of these 2 proteins was further evaluated by Western blotting with an anti-EGFP antibody.
restrict the involvement of any unrelated proteins in this assay, the EGFP-kindlin-3-coupled microbeads were extensively washed and no unexpected protein band was detected after SDS-PAGE and coomassie blue staining (data not shown). As shown in Figure 1B , when compared with EGFP control, EGFPkindlin-3 on the microbeads displayed a significant interaction with the integrin β 3 CT peptides. However, kindlin-3 with the QW/AA substitution exhibited a dramatically reduced interaction with the integrin β 3 CT peptides. These results demonstrate that the QW/AA substitution in kindlin-3 significantly perturbs the interaction between kindlin-3 and integrin β 3 CT. To consider whether the QW/AA substitution affected the structural stability of kindlin-3 protein, EGFP-kindlin-3 and the QW/ AA mutant expressed in CHO cells were loaded on a native gel and their mobilities on nondenaturing gels were assessed by Western blotting. As shown in Figure 1C , kindlin-3 protein and the QW/AA mutant migrated identically, suggesting that the kindlin-3 mutant exhibits a similar structural stability with its wild-type (WT) counterpart. We also noted that the expression levels of EGFP-kindlin-3 and the EGFP-fused QW/AA mutant form were similar in several mammalian cell lines, HEL, K562 and RAW cells (data not shown), which is also consistent with similar folding of the 2 kindlin-3 molecules. Therefore, our results suggest that kindlin-3 shares the same recognition mechanism as kindlin-1 and kindlin-2 binding to integrin β CT and the QW/AA substitutions can be used to perturb the interaction between kindlins and integrin specifically.
Generation of K3KI Mice That Carry the QW/AA Substitution
To evaluate the functional significance of the direct interaction between kindlin-3 and integrin in vivo, a K3KI allele in which a double-mutation (QW/AA) was introduced into the kindlin-3 gene locus (Figure 2A and 2B) was used to generate K3KI mice. K3KI mice were born in expected Mendelian ratios and were fertile. Significantly, K3KI mice showed normal survival (mice of >6 months with no overt signs of ill-health), which is different from kindlin-3 −/− mice, which only survive 1 week postnatally. 13 Spontaneous bleeding was not observed in K3KI mice, and platelet counts in peripheral blood of K3KI mice were comparable with those in WT mice ( Figure 2C ). As with kindlin-3 −/− mice, 25 K3KI mice exhibited significant leukocytosis ( Figure 2D ). In contrast to the kindlin-3 knockout mice, which were severely anemic, 25 red blood cells in peripheral blood of K3KI mice were only slightly suppressed ( Figure 2E ). We did note some acanthocytes in blood smears of some of the K3KI mice as was reported in the kindlin-3 −/− mice, 26 but this varied among the individual K3KI mice and is being further explored.
We examined the expression of integrin αIIbβ3 on platelets by flow cytometry and found that integrin αIIbβ3 expression levels were identical on WT and K3KI platelets ( Figure 2F ). The expression of kindlin-3 protein in washed platelets from WT and K3KI mice was similar as assessed by Western blots ( Figure 2G ). In addition, 2 other proteins with important roles in integrin activation, talin, and Rap1 (Rap1a+Rap1b) were also expressed at similar levels in K3KI and WT platelets ( Figure 2G) . Significantly, the results of coimmunoprecipitation experiments showed that integrin αIIbβ3 markedly reduced its association with the kindlin-3 mutant in K3KI platelets (≈ 85% reduction) when compared with the association between integrin αIIbβ3 and kindlin-3 in WT platelets under the same conditions ( Figure 2H ). Thus, we successfully generated a strain of mice expressing a kindlin-3 mutant with Figure 2 . Generation of kindlin-3 gene knockin (K3KI) mice that carry the QW/AA mutation. A, A diagram illustrating the gene-targeting strategy for generating K3KI mice. The numbered rectangles represent kindlin-3 gene exons and the mutated nucleotides (CAATGG to GCCGCC) locate in exon14 (*). Neo r represents the neomycin cassette, which was used for selecting positive embryonic stem cell clones. The 5′ and 3′ arms for homologous recombination are highlighted. The inserted flippase recognition target (FRT) sequences were used to remove the neomycin cassette. B, Targeted genomic DNA fragment was amplified by polymerase chain reaction from the selected embryonic stem clones and sequenced, and the mutated sites in the kindlin-3 gene were verified. C, Platelet counts in peripheral blood of WT and K3KI mice were measured, and no significant difference was found between them. D, The counts of leukocytes in peripheral blood of K3KI mice were significantly elevated when compared with wild-type (WT) mice (**P<0.01). E, Red blood cell counts in peripheral blood of WT and K3KI mice (*P<0.05). F, Cell surface expression of integrin αIIbβ3 on K3KI platelets and WT counterparts was measured by flow cytometry using a phycoerythrin-conjugated anti-mouse CD41 antibody. G, Washed platelets from WT and K3KI mice were lysed, and the expression of kindlin-3 (Kind-3), talin, and Rap1 (Rap1a and Rap1b) proteins in platelets was evaluated by Western blotting. Actin was also measured as a loading control. H, Integrin αIIbβ3 was immunoprecipitated from the platelet lysates, and kindlin-3 and integrin β 3 in the precipitates were measured by Western blotting. a significant reduction in integrin-binding activity, which can be used to evaluate the functional significance of the interaction between kindlin-3 and integrin in hematopoietic cells.
Interaction Between Kindlin-3 and Integrin αIIbβ3 in Platelets Facilitates αIIbβ3 Activation and Is Essential for αIIbβ3-Mediated Platelet Spreading
To evaluate whether the direct interaction between the kindlin-3 QW sequence and integrin affects hemostasis, tail bleeding assays were performed on WT and K3KI mice. After a small portion of tail-tip was removed, the bleeding time was measured. The results revealed that K3KI mice displayed a significantly prolonged bleeding time when compared with their WT counterparts ( Figure 3A) . In WT mice, the mean bleeding time was 211±126 s (n=8), whereas the bleeding time of all K3KI mice (n=8) exceeded 600 s. Thus, the QW/AA substitution in kindlin-3 led to a severe hemostatic defect in K3KI mice. The extended bleeding time from K3KI mice led us to analyze integrin αIIbβ3 signaling in K3KI platelets. Integrin inside-out signaling was evaluated by agonist-induced soluble fibrinogen binding to αIIbβ3 on platelets. As shown in Figure 3B , integrin αIIbβ3 activation on K3KI platelets was completely inhibited on stimulation with ADP (20 μmol/L) and partially but significantly inhibited in response to protease-activated receptor 4 (PAR-4) agonist peptide (AYPGKF, 150 μmol/L) or collagen-related peptide (2 μg/mL). As assessed by flow cytometry, the inhibition was ≈50% in mean fluorescence intensity. The residual fibrinogen binding to K3KI platelets in the presence of PAR-4 agonist peptide or collagen-related peptide suggests that K3KI platelets still retain some ability to support integrin αIIbβ3 insideout signaling in response to strong stimuli.
Next, we measured the spreading of K3KI platelets on immobilized fibrinogen and found that integrin αIIbβ3-mediated K3KI platelet spreading was significantly compromised (Figure 3C ), demonstrating that interaction with kindlin-3 is essential for integrin αIIbβ3 to mediate outside-in signaling. In spite of the impaired bidirectional signaling of integrin αIIbβ3 , and collagen-related peptide (CRP; 2 μg/mL; **P<0.01). C, Washed platelets from K3KI mice and WT counterparts were allowed to adhere and spread on immobilized fibrinogen for 120 minutes in a tissue culture incubator. After washing, the adherent platelets were fixed, permeabilized, and stained with rhodamine-conjugated phalloidin and the images were captured under a fluorescence microscope (×100 objective). Spreading areas of adherent platelets were quantified using Metamorph software (*P<0.05). D, Representative traces to show the aggregation kinetics of WT and K3KI platelets stimulated with different doses of the indicated agonists. E, Photograph of thrombin-induced clot retraction of PRP containing WT and K3KI platelets.
on K3KI platelets, degranulation was unaffected; P-selectin translocation to the platelet surface on WT and K3KI platelets in response to stimulation with PAR-4 agonist peptide or collagen-related peptide was identical (data not shown). In addition, the fibrinogen levels in WT and K3KI platelets were similar as evaluated by Western blots (data not shown).
Interaction Between Kindlin-3 and Integrin αIIbβ3 in Platelets Supports Platelet Aggregation and Clot Retraction
Next, ex vivo platelet aggregation studies were performed in response to different agonists. As shown in Figure 3D , K3KI platelets showed negligible aggregation in response to ADP and only a weak response to U46619 when compared with WT platelets. Notably, partial aggregation of K3KI platelets was observed in response to collagen and thrombin. The capacity of K3KI platelets to retain an ability to aggregate in response to higher doses of strong agonists differs from previous observations on kindlin-3 −/− platelets, which had negligible responses to all agonists tested. 13 We also evaluated clot retraction induced by platelets from WT and K3KI mice as a response driven by αIIbβ3-mediated outside-in signaling. Using high doses of thrombin, sufficient to induce aggregation, K3KI platelets failed to support clot retraction ( Figure 3E ), whereas WT platelets retracted well. Taken together, these findings demonstrate that the QW sequence-mediated interaction of kindlin-3 with integrin αIIbβ3 on platelets is important for supporting platelet aggregation and essential for clot retraction.
Interaction Between Kindlin-3 and Integrin Is Essential for Thrombus Formation In Vitro
To evaluate the functional significance of the direct interaction between kindlin-3 and integrin in platelets further, an in vitro thrombus formation assay was performed under flow conditions using a whole blood microfluidic perfusion system as previously described. 32 Platelets in whole blood were labeled with mepacrine and allowed to flow over a collagen-coated surface at 80 dynes/cm 2 . The adhesion and aggregation of platelets were visualized as the accumulation of fluorescence on the collagen-coated surface. As shown in Figure 4A , platelet adhesion was markedly diminished and thrombus formation was severely hampered in blood from K3KI mice in contrast with the strong signal for both platelet adhesion and thrombus formation obtained with blood from WT mice at the same conditions. This experiment was repeated twice and similar results were obtained. The calculated percentage of surface fluorescence coverage or total integrated fluorescence intensity per square micrometer area at different time points was increased ≈30-fold for blood from WT mice when compared with that from K3KI mice, suggesting that a direct interaction between kindlin-3 and integrin in platelets is essential for efficient platelet-mediated thrombus formation in this in vitro assay.
Crosstalk Between Kindlin-3 and Integrin in Platelets Is Essential for Arterial Thrombus Formation In Vivo
The function of K3KI platelets in vivo was measured in a FeCl 3 -induced arterial thrombosis model. A transit-time perivascular flowmeter was used to monitor blood flow in the carotid artery after a 3-minute vascular injury with 10% FeCl 3 . Data from 5 mice are shown in Figure 4B . For WT mice, stable occlusion occurred within 15 minutes. In contrast, occlusion failed to occur in the arteries of K3KI mice within the testing time (45 minutes). These results show that contact between kindlin-3 and integrin in platelets is required to support arterial thrombus formation in vivo.
Discussion
The pathogenesis of human LAD-III has been attributed to the absence of kindlin-3 protein expression in hematopoietic cells because of heritable mutations in kindlin-3 gene in patients. 23 It has been well documented that kindlin-3 is required to support integrin activation in hematopoietic cells. 13, 19, 20, 25 However, the molecular mechanisms involved are still poorly understood. Proteomic analysis disclosed that the expression levels of multiple proteins in kindlin-3-deficient murine cells could be either up or downregulated, 26 bringing some uncertainty to the cause of integrin dysfunction in hematopoietic cells. Although kindlin-3 has been categorized as an integrin-binding protein, the functional significance of the direct interaction between kindlin-3 and integrin αIIbβ3 in platelets still remains unknown. By mutagenesis, it has been demonstrated that the kindlin-3-binding sites in the integrin β 3 CT (NITY 759 motif) is critical for supporting integrin αIIbβ3 activation. 12, 33 However, the NITY 759 motif in the β 3 CT is in a region that can mediate . Time-course images of platelet adhesion and aggregation were acquired using epifluorescence microscopy. B, The mouse carotid artery was exposed and stimulated with 10% FeCl 3 . After that, blood flow in the carotid artery was monitored by a transit-time flowmeter. Zero on the x axis represents the time at which filter paper saturated with FeCl 3 solution was removed from the surface of the artery. The times to occlusion were measured (**P<0.01).
interaction with multiple proteins 34, 35 so that mutations in this region could possibly produce off-target effects. In our present study, we generated a K3KI mouse model harboring a QW/ AA substitution in kindlin-3 protein to disconnect kindlin-3 from integrins in hematopoietic cells. The value of the K3KI mouse model include (1) K3KI mice have normal expression levels of kindlin-3 protein in platelets, which limits possible indirect effects resulting from the absence of kindlin-3 protein; (2) Theoretically, the QW/AA substitution in kindlin-3 protein should be able to disconnect kindlin-3 from multiple integrin members in hematopoietic cells, but these limited and specific point mutations should not perturb nonintegrin-dependent kindlin functions 30 ; (3) The interaction of integrin with other integrin CT-binding partners also should not be directly affected in K3KI cells. These features suggest that K3KI mouse provides a unique opportunity to evaluate the integrin-kindlin-3 signaling in vivo. Using this model, we demonstrate that the direct interaction between kindlin-3 and integrin αIIbβ3 in platelets is essential for supporting certain platelet function and arterial thrombus formation, which could not be concluded from the previous studies on patients with LAD-III and kindlin-3 null mice, thus representing an important step forward in our understanding kindlin-3s function in platelets.
Unlike kindlin-3-deficient platelets, which display minimal integrin αIIbβ3 activation and aggregation in response to all agonists, 13 we found that high concentrations of agonists, such as thrombin and collagen, still could induce significant integrin αIIbβ3 activation ( Figure 3B ) and aggregation of K3KI platelets ( Figure 3D) . Indeed, at a higher thrombin concentration, the extent of aggregation of K3KI platelets nearly approached that of WT platelets. Possible interpretations include (1) the interaction of the kindlin-3 QW/AA mutant with integrins in K3KI platelets is compromised but not eliminated; a weak interaction could still occur, which might be sufficient, together with talin, to induce platelet aggregation in the face of a strong stimulus; (2) the kindlin-3 QW/AA mutant might use a mechanism involving the third molecule, such as ADAP, or a signaling pathway to support integrin function, which is independent of the direct interaction between kindlin-3 and integrins and which is operative at high doses of strong agonists. 28 Additional studies will be required to address these possibilities. Nonetheless, in vivo platelet aggregation in K3KI mice under pathological conditions was significantly suppressed, suggesting that the ex vivo K3KI platelet aggregation under strong stimulations may not have the opportunity to occur in vivo.
Although significant ex vivo platelet aggregation could be induced by thrombin (0.1-0.2 U/mL) for K3KI platelets ( Figure 3D ), the aggregates formed at a high thrombin concentration (0.8 U/mL) failed to support K3KI plateletmediated clot retraction ( Figure 3E ), raising a possibility that kindlin-3 may use distinct mechanisms in supporting integrin αIIbβ3-mediated platelet aggregation (inside-out signaling dependent) and clot retraction (outside-in signaling dependent). The profound effect of kindlin-3 QW/AA mutation on platelet spreading is consistent with the major importance of kindlin-3 in outside-in signaling across integrin αIIbβ3. Hypothetically, the absence of or a weak interaction between integrin αIIbβ3 and kindlin-3 in K3KI platelets may fail to sustain the high mechanical forces between platelet integrin αIIbβ3 and fibrinogen/fibrin, thus leading to clot retraction defects for K3KI platelets. Alternatively, kindlin-3, such as talin, 36 may play distinct roles in orchestrating different integrin-dependent functions.
In summary, our findings in this study demonstrate the importance of the direct interaction between kindlin-3 and integrin αIIbβ3 in platelets for supporting integrin αIIbβ3-mediated platelet responses and arterial thrombosis, thus furthering our understanding of the molecular regulation of kindlin-3 signaling in platelets.
